Pam Devreker No current affiliation with UGent 1 – 2 of 2 publications Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Filter publications Download search results Subscribe to news feed Add to list Journal Article A1 open access Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials Joline Ingels (UGent) , Laurenz De Cock, Rupert Mayer (UGent) , Pam Devreker (UGent) , Karin Weening (UGent) , Kelly Heyns (UGent) , Nele Lootens (UGent) , Saskia De Smet (UGent) , Marieke Brusseel (UGent) , Stijn De Munter (UGent) , et al. (2022) CYTOTHERAPY. 24(2). p.213-222 Add to list Journal Article A1 An accelerated, clinical-grade protocol to generate high yields of type 1-polarizing messenger RNA loaded dendritic cells for cancer vaccination Elisabeth Brabants (UGent) , Kelly Heyns (UGent) , S De Smet, Pam Devreker (UGent) , Joline Ingels (UGent) , Nancy De Cabooter (UGent) , Veronique Debacker (UGent) , Melissa Dullaers (UGent) , JP Van Meerbeeck, Bart Vandekerckhove (UGent) , et al. (2018) CYTOTHERAPY. 20(9). p.1164-1181
